These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8573216)

  • 21. A double inhibition kinetic analysis of [3H]-muscimol binding to the gamma-aminobutyric acid receptor on calf brain synaptic membranes. Further studies on the mechanism of homocysteine-induced seizures.
    Griffiths R; Egbuta JO
    Biochem Pharmacol; 1985 Oct; 34(19):3553-9. PubMed ID: 2996552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclothiazide binding to the GABAA receptor.
    Szárics E; Simon A; Visy J; Simon-Trompler E; Banka Z; Héja L; Hársing LG; Blaskó G; Kardos J
    Neurosci Lett; 2008 Jul; 439(1):66-9. PubMed ID: 18502046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [3H]LY341495 binding to group II metabotropic glutamate receptors in rat brain.
    Wright RA; Arnold MB; Wheeler WJ; Ornstein PL; Schoepp DD
    J Pharmacol Exp Ther; 2001 Aug; 298(2):453-60. PubMed ID: 11454905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rigid analogs of taurine as potential taurine antagonists.
    Braghiroli D; Di Bella M; Zanoli P; Truzzi C; Baraldi M
    Farmaco; 1990 Jun; 45(6):631-45. PubMed ID: 2176787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CNS 7056: a novel ultra-short-acting Benzodiazepine.
    Kilpatrick GJ; McIntyre MS; Cox RF; Stafford JA; Pacofsky GJ; Lovell GG; Wiard RP; Feldman PL; Collins H; Waszczak BL; Tilbrook GS
    Anesthesiology; 2007 Jul; 107(1):60-6. PubMed ID: 17585216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sedative and sleep-enhancing properties of linarin, a flavonoid-isolated from Valeriana officinalis.
    Fernández S; Wasowski C; Paladini AC; Marder M
    Pharmacol Biochem Behav; 2004 Feb; 77(2):399-404. PubMed ID: 14751470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic inhibition of [3H]muscimol binding to calf-brain synaptic membranes in the presence of L-homocysteine and pyridoxal 5'-phosphate. A possible mechanism for homocysteine-induced seizures.
    Griffiths R; Williams DC; O'Neill C; Dewhurst IC; Ekuwem CE; Sinclair CD
    Eur J Biochem; 1983 Dec; 137(3):467-78. PubMed ID: 6319125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kavapyrone enriched extract from Piper methysticum as modulator of the GABA binding site in different regions of rat brain.
    Jussofie A; Schmiz A; Hiemke C
    Psychopharmacology (Berl); 1994 Dec; 116(4):469-74. PubMed ID: 7701051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [3H]gabapentin may label a system-L-like neutral amino acid carrier in brain.
    Thurlow RJ; Brown JP; Gee NS; Hill DR; Woodruff GN
    Eur J Pharmacol; 1993 Nov; 247(3):341-5. PubMed ID: 8307106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presence of a low molecular weight endogenous inhibitor on 3H-muscimol binding in synaptic membranes.
    Yoneda Y; Kuriyama K
    Nature; 1980 Jun; 285(5767):670-3. PubMed ID: 6248791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-Aminolevulinic acid inhibits [3H]muscimol binding to human and rat brain synaptic membranes.
    Emanuelli T; Pagel FW; Alves LB; Regner A; Souza DO
    Neurochem Res; 2001 Feb; 26(2):101-5. PubMed ID: 11478735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extraction of valerenic acids from valerian (Valeriana officinalis L.) rhizomes.
    Boyadzhiev L; Kancheva D; Gourdon C; Metcheva D
    Pharmazie; 2004 Sep; 59(9):727-8. PubMed ID: 15497760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites.
    Akahane K; Sekiguchi M; Une T; Osada Y
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1704-8. PubMed ID: 2556076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of muscimol and GABA in sub-fractions of a crude membrane fraction of rat brain.
    Varga V; DeFeudis FV; Ossola L; Geffard M; Mandel P
    Biochem Pharmacol; 1980 Apr; 29(7):1077-9. PubMed ID: 7387722
    [No Abstract]   [Full Text] [Related]  

  • 35. HPLC-Based Activity Profiling for GABA
    Moradi-Afrapoli F; Ebrahimi SN; Smiesko M; Hamburger M
    J Nat Prod; 2017 May; 80(5):1548-1557. PubMed ID: 28485933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In silico screening of GABA aminotransferase inhibitors from the constituents of Valeriana officinalis by molecular docking and molecular dynamics simulation study.
    Park JY; Lee Y; Lee HJ; Kwon YS; Chun W
    J Mol Model; 2020 Aug; 26(9):228. PubMed ID: 32780180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Review Focused on Molecular Mechanisms of Anxiolytic Effect of Valerina officinalis L. in Connection with Its Phytochemistry through in vitro/in vivo Studies.
    Orhan IE
    Curr Pharm Des; 2021; 27(28):3084-3090. PubMed ID: 33463459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Valeriana officinalis and Crataegus oxyacantha: toxicity from repeated administration and pharmacologic investigations].
    Fehri B; Aiache JM; Boukef K; Memmi A; Hizaoui B
    J Pharm Belg; 1991; 46(3):165-76. PubMed ID: 1757878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Some characteristics of solubilized and partially purified cerebral GABA and benzodiazepine receptors.
    Kuriyama K; Ito Y
    Adv Biochem Psychopharmacol; 1983; 37():59-70. PubMed ID: 6314773
    [No Abstract]   [Full Text] [Related]  

  • 40. Kynurenine may directly interact with GABA receptors in rat brain.
    Pinelli A; Govoni S; Ossi C; Battaini F; Caimi BR; Trivulzio S
    Pharmacology; 1985; 30(5):255-8. PubMed ID: 2987981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.